Published in J Womens Health (Larchmt) on December 01, 2005
Lipid profile in consecutive pregnancies. Lipids Health Dis (2010) 0.82
CARDIA: study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol (1988) 15.40
High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med (1977) 15.39
Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis (1988) 6.01
Weight gain continues in the 1990s: 10-year trends in weight and overweight from the CARDIA study. Coronary Artery Risk Development in Young Adults. Am J Epidemiol (2000) 4.49
Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. Am J Epidemiol (2002) 3.48
Cardiovascular risk factors in young adults. The CARDIA baseline monograph. Control Clin Trials (1991) 3.30
The CARDIA dietary history: development, implementation, and evaluation. J Am Diet Assoc (1991) 3.04
Seven-year trends in body weight and associations with lifestyle and behavioral characteristics in black and white young adults: the CARDIA study. Am J Public Health (1997) 2.01
Plasma estrone, estradiol, estriol, progesterone, and 17-hydroxyprogesterone in human pregnancy. I. Normal pregnancy. Am J Obstet Gynecol (1972) 1.76
Change and secular trends in physical activity patterns in young adults: a seven-year longitudinal follow-up in the Coronary Artery Risk Development in Young Adults Study (CARDIA). Am J Epidemiol (1996) 1.73
Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study. JAMA (1994) 1.71
Seven-year trends in plasma low-density-lipoprotein-cholesterol in young adults: the CARDIA Study. Ann Epidemiol (1996) 1.53
APOE genotype as a risk factor for ischemic cerebrovascular disease: a meta-analysis. Neurology (1999) 1.43
Is normal pregnancy atherogenic? Clin Sci (Lond) (1999) 1.31
Long-term plasma lipid changes associated with a first birth: the Coronary Artery Risk Development in Young Adults study. Am J Epidemiol (2004) 1.30
High-density lipoproteins: epidemiologic profile and risks of coronary artery disease. Am J Cardiol (1983) 1.28
Parity and carotid artery atherosclerosis in elderly women: The Rotterdam Study. Stroke (2001) 1.27
Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery disease. Am J Cardiol (1993) 1.22
Twelve-year incidence of coronary heart disease in middle-aged adults during the era of hypertensive therapy: the Framingham offspring study. Am J Med (1991) 1.22
Reference ranges of lipids and apolipoproteins in pregnancy. Eur J Obstet Gynecol Reprod Biol (1992) 1.18
Lipid metabolism in pregnancy. Br J Obstet Gynaecol (1982) 1.16
Adverse effect of pregnancy on high density lipoprotein (HDL) cholesterol in young adult women. The CARDIA Study. Coronary Artery Risk Development in Young Adults. Am J Epidemiol (1996) 1.14
Serum lipids in young women before, during, and after pregnancy. Am J Epidemiol (1987) 1.11
Apolipoprotein E genotype affects plasma lipid response to atorvastatin in a gender specific manner. Atherosclerosis (2001) 1.05
Genetic studies of human apolipoproteins. V. A novel rapid procedure to screen apolipoprotein E polymorphism. J Lipid Res (1988) 1.04
Longitudinal study of plasma lipids and lipoprotein cholesterol in normal pregnancy and puerperium. Gynecol Obstet Invest (1988) 1.03
Reciprocal effects of apolipoprotein E alleles (epsilon 2 and epsilon 4) on plasma lipid levels in normolipidemic subjects. Clin Genet (1986) 1.03
Association of apolipoprotein E phenotype with plasma lipoproteins in African-American and white young adults. The CARDIA Study. Coronary Artery Risk Development in Young Adults. Am J Epidemiol (1998) 0.97
The relationship between multiparity and lipoprotein levels in older women. J Clin Epidemiol (1992) 0.96
APO E gene and gene-environment effects on plasma lipoprotein-lipid levels. Physiol Genomics (2000) 0.95
Lipoprotein lipase and apoE polymorphisms: relationship to hypertriglyceridemia during pregnancy. J Lipid Res (2001) 0.94
Oral contraceptives and lipids. BMJ (1989) 0.93
Apolipoprotein E gene expression in various tissues of mouse and regulation by estrogen. Biochem Mol Biol Int (1996) 0.91
Simplified isoelectric focusing/immunoblotting determination of apoprotein E phenotype. Clin Chem (1994) 0.90
Carbohydrate and lipid metabolism during normal pregnancy: relationship to gestational hormone action. Semin Perinatol (1978) 0.90
Adverse influences of alcohol, tobacco, and oral contraceptive use on cardiovascular risk factors during transition to adulthood. Am J Epidemiol (1987) 0.87
Influence of apolipoprotein E polymorphism on serum lipids and lipoprotein changes from childhood to adulthood: the Bogalusa Heart Study. Atherosclerosis (1999) 0.86
Associations of oral contraceptive use with serum lipids and lipoproteins in young women: the Bogalusa Heart Study. Ann Epidemiol (1997) 0.85
Expression of mouse alpha-macroglobulins, lipoprotein receptor-related protein, LDL receptor, apolipoprotein E, and lipoprotein lipase in pregnancy. J Lipid Res (1995) 0.84
Cross-sectional and longitudinal associations between high density lipoprotein cholesterol and women's employment. Am J Epidemiol (1992) 0.83
Estrogen increases hepatic lipase levels in inbred strains of mice: a possible mechanism for estrogen-dependent lowering of high density lipoprotein. Mol Cell Biochem (2001) 0.82
Plasma lipids and desogestrel and ethinyl estradiol: a meta-analysis. Fertil Steril (1996) 0.82
Gene-diet interactions and plasma lipoproteins: role of apolipoprotein E and habitual saturated fat intake. Genet Epidemiol (2001) 0.82
Estrogen replacement therapy, serum lipids, and polymorphism of the apolipoprotein E gene. Clin Chem (1999) 0.81
Estrogen modulation of apolipoprotein(a) expression. Identification of a regulatory element. J Biol Chem (1999) 0.80
Is the response of serum lipids and lipoproteins to postmenopausal hormone replacement therapy modified by ApoE genotype? Arterioscler Thromb Vasc Biol (1999) 0.79
Apolipoprotein E genotype and response of lipid levels to postmenopausal estrogen use. Atherosclerosis (2002) 0.78
Relationship between apolipoprotein E polymorphism, menopausal symptoms, and serum lipids during hormone replacement therapy. Eur J Obstet Gynecol Reprod Biol (1998) 0.77
Metabolic regulation of plasma apolipoprotein E by estrogen and progesterone in the baboon (Papio sp). Metabolism (1991) 0.77
Multicenter study of endocrine function and plasma lipids and lipoproteins in women using oral contraceptives containing desogestrel progestin. UK Desogen Study Group. Contraception (1997) 0.77
Apolipoproteins E and C-III in apo B- and non-apo B-containing lipoproteins in middle-aged women from the Stanislas cohort: effect of oral contraceptive use and common apolipoprotein E polymorphism. Atherosclerosis (2001) 0.76
Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA (2004) 23.69
A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med (2015) 19.14
Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med (2013) 15.58
Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation (2006) 14.72
Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care (2007) 14.35
Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA (2006) 12.44
Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med (2006) 12.09
Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med (2006) 8.73
Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med (2010) 8.28
The Look AHEAD study: a description of the lifestyle intervention and the evidence supporting it. Obesity (Silver Spring) (2006) 8.25
The Women's Health Initiative Observational Study: baseline characteristics of participants and reliability of baseline measures. Ann Epidemiol (2003) 7.49
Association of weight status with mortality in adults with incident diabetes. JAMA (2012) 7.49
Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet (2007) 7.27
Effects of Testosterone Treatment in Older Men. N Engl J Med (2016) 6.66
Calcium/vitamin D supplementation and cardiovascular events. Circulation (2007) 6.63
Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med (2014) 6.54
Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA (2009) 5.75
Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study. Diabetes Care (2011) 5.63
Racial differences in incident heart failure among young adults. N Engl J Med (2009) 5.60
Weight loss to treat urinary incontinence in overweight and obese women. N Engl J Med (2009) 5.58
Smoking and mortality--beyond established causes. N Engl J Med (2015) 5.54
Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study. BMJ (2005) 5.34
High-trauma fractures and low bone mineral density in older women and men. JAMA (2007) 5.00
Fast food restaurants and food stores: longitudinal associations with diet in young to middle-aged adults: the CARDIA study. Arch Intern Med (2011) 4.40
A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients. Breast Cancer Res (2006) 4.28
Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial. JAMA (2003) 4.07
Association between radiographic features of knee osteoarthritis and pain: results from two cohort studies. BMJ (2009) 3.99
Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis. BMJ (2010) 3.98
Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial. JAMA (2011) 3.85
Improved blood pressure control associated with a large-scale hypertension program. JAMA (2013) 3.80
An increase in the incidence of gestational diabetes mellitus: Northern California, 1991-2000. Obstet Gynecol (2004) 3.77
Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection? J Acquir Immune Defic Syndr (2002) 3.33
Validity of self-report for fractures among a multiethnic cohort of postmenopausal women: results from the Women's Health Initiative observational study and clinical trials. Menopause (2004) 3.33
A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies. Lancet (2012) 3.20
Meniscal tear in knees without surgery and the development of radiographic osteoarthritis among middle-aged and elderly persons: The Multicenter Osteoarthritis Study. Arthritis Rheum (2009) 3.19
HIV infection and the risk of cancers with and without a known infectious cause. AIDS (2009) 3.13
Preclinical atherosclerosis due to HIV infection: carotid intima-medial thickness measurements from the FRAM study. AIDS (2009) 3.12
Mortality and cardiac and vascular outcomes in extremely obese women. JAMA (2006) 3.09
Association of race and sex with risk of incident acute coronary heart disease events. JAMA (2012) 3.07
A multisite study of long-term remission and relapse of type 2 diabetes mellitus following gastric bypass. Obes Surg (2013) 3.06
Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA (2006) 2.97
Cardiorespiratory fitness in young adulthood and the development of cardiovascular disease risk factors. JAMA (2003) 2.93
COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. Chest (2005) 2.88
Factors associated with 5-year risk of hip fracture in postmenopausal women. JAMA (2007) 2.81
The role of postpartum weight retention in obesity among women: a review of the evidence. Ann Behav Med (2003) 2.79
Maintaining a high physical activity level over 20 years and weight gain. JAMA (2010) 2.78
Susceptibility locus for clinical and subclinical coronary artery disease at chromosome 9p21 in the multi-ethnic ADVANCE study. Hum Mol Genet (2008) 2.71
Epidemiology of menthol cigarette use. Nicotine Tob Res (2004) 2.66
Maternal exposure to toxoplasmosis and risk of schizophrenia in adult offspring. Am J Psychiatry (2005) 2.60
Review of medical encounters in the 5 years before a diagnosis of HIV-1 infection: implications for early detection. J Acquir Immune Defic Syndr (2003) 2.55
Racial/ethnic variation in asthma status and management practices among children in managed medicaid. Pediatrics (2002) 2.54
Prehypertension during young adulthood and coronary calcium later in life. Ann Intern Med (2008) 2.49
Gamma-glutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Clin Chem (2003) 2.49
Mortality, health outcomes, and body mass index in the overweight range: a science advisory from the American Heart Association. Circulation (2009) 2.49
The study of fat redistribution and metabolic change in HIV infection (FRAM): methods, design, and sample characteristics. Am J Epidemiol (2006) 2.44
Screening statins for possible carcinogenic risk: up to 9 years of follow-up of 361,859 recipients. Pharmacoepidemiol Drug Saf (2008) 2.43
Plasma F2-isoprostanes and coronary artery calcification: the CARDIA Study. Clin Chem (2004) 2.40
Early adult risk factor levels and subsequent coronary artery calcification: the CARDIA Study. J Am Coll Cardiol (2007) 2.38
Alcohol consumption, binge drinking, and early coronary calcification: findings from the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Am J Epidemiol (2005) 2.35
Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies. Ann Intern Med (2008) 2.33
Current use of unopposed estrogen and estrogen plus progestin and the risk of acute myocardial infarction among women with diabetes: the Northern California Kaiser Permanente Diabetes Registry, 1995-1998. Circulation (2003) 2.32
Next generation genome-wide association tool: design and coverage of a high-throughput European-optimized SNP array. Genomics (2011) 2.31
Erectile dysfunction in type 2 diabetic men: relationship to exercise fitness and cardiovascular risk factors in the Look AHEAD trial. J Sex Med (2009) 2.30
Risk of recurrent childhood arterial ischemic stroke in a population-based cohort: the importance of cerebrovascular imaging. Pediatrics (2007) 2.29
Human epidermal growth factor receptor 2 assessment in a case-control study: comparison of fluorescence in situ hybridization and quantitative reverse transcription polymerase chain reaction performed by central laboratories. J Clin Oncol (2010) 2.28
Microalbuminuria in HIV infection. AIDS (2007) 2.28
Head computed tomography findings predict short-term stroke risk after transient ischemic attack. Stroke (2003) 2.28
Post-diagnosis statin use and breast cancer recurrence in a prospective cohort study of early stage breast cancer survivors. Breast Cancer Res Treat (2007) 2.27
Racial/Ethnic differences in longitudinal risk of intracranial hemorrhage in brain arteriovenous malformation patients. Stroke (2007) 2.26
Immigration and acculturation in relation to health and health-related risk factors among specific Asian subgroups in a health maintenance organization. Am J Public Health (2004) 2.26
Active commuting and cardiovascular disease risk: the CARDIA study. Arch Intern Med (2009) 2.24
Body mass index in midlife and risk of Alzheimer disease and vascular dementia. Curr Alzheimer Res (2007) 2.19
Lack of association between the Trp719Arg polymorphism in kinesin-like protein-6 and coronary artery disease in 19 case-control studies. J Am Coll Cardiol (2010) 2.17
Self-reported experiences of racial discrimination and Black-White differences in preterm and low-birthweight deliveries: the CARDIA Study. Am J Public Health (2004) 2.17
Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial. J Natl Cancer Inst (2005) 2.16
Risk factors for the metabolic syndrome: the Coronary Artery Risk Development in Young Adults (CARDIA) study, 1985-2001. Diabetes Care (2004) 2.12
Physical activity and changes in weight and waist circumference in midlife women: findings from the Study of Women's Health Across the Nation. Am J Epidemiol (2004) 2.11
Association between marijuana exposure and pulmonary function over 20 years. JAMA (2012) 2.09
Older age and the response to and tolerability of antiretroviral therapy. Arch Intern Med (2007) 2.07
Heavy smoking in midlife and long-term risk of Alzheimer disease and vascular dementia. Arch Intern Med (2010) 2.04
HIV infection, immunodeficiency, viral replication, and the risk of cancer. Cancer Epidemiol Biomarkers Prev (2011) 2.02
Fifteen-year longitudinal trends in walking patterns and their impact on weight change. Am J Clin Nutr (2008) 2.01
Menthol cigarettes, smoking cessation, atherosclerosis, and pulmonary function: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Arch Intern Med (2006) 2.01
Waist circumference correlates with metabolic syndrome indicators better than percentage fat. Obesity (Silver Spring) (2006) 2.00
Calcium/vitamin D supplementation and coronary artery calcification in the Women's Health Initiative. Menopause (2010) 2.00
Prepregnancy SHBG concentrations and risk for subsequently developing gestational diabetes mellitus. Diabetes Care (2014) 1.98
Homocysteine, B vitamins, and the incidence of dementia and cognitive impairment: results from the Sacramento Area Latino Study on Aging. Am J Clin Nutr (2007) 1.98
Association of upper trunk and visceral adipose tissue volume with insulin resistance in control and HIV-infected subjects in the FRAM study. J Acquir Immune Defic Syndr (2007) 1.98